A Lox/CHOP-10 crosstalk governs osteogenic and adipogenic cell fate by MSCs

12Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

Abstract

Accelerated marrow adipogenesis has been associated with ageing and osteoporosis and is thought to be because of an imbalance between adipogenic and osteogenic differentiation of mesenchymal stem cell (MSCs). We have previously found that lysyl oxidase (Lox) inhibition disrupts BMP4-induced adipocytic lineage commitment and differentiation of MSCs. In this study, we found that lox inhibition dramatically up-regulates BMP4-induced expression of CCAAT/enhancer binding protein (C/EBP) homologous protein 10 (CHOP-10), which then promotes BMP4-induced osteogenesis of MSCs both in vitro and in vivo. Specifically, Lox inhibition or CHOP-10 up-regulation activated Wnt/β-catenin signalling to enhance BMP4-induced osteogenesis, with pro-adipogenic p38 MAPK and Smad signalling suppressed. Together, we demonstrate that Lox/CHOP-10 crosstalk regulates BMP4-induced osteogenic and adipogenic fate determination of MSCs, presenting a promising therapeutic target for osteoporosis and other bone diseases.

Cite

CITATION STYLE

APA

Jiang, W. Y., Xing, C., Wang, H. W., Wang, W., Chen, S. Z., Ning, L. F., … Huang, H. Y. (2018). A Lox/CHOP-10 crosstalk governs osteogenic and adipogenic cell fate by MSCs. Journal of Cellular and Molecular Medicine, 22(10), 5097–5108. https://doi.org/10.1111/jcmm.13798

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free